SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HRC HEALTHSOUTH -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (166)9/16/2001 6:22:26 PM
From: Toby Zidle  Read Replies (2) | Respond to of 181
 
I've been reviewing the past 50 or so postings on the HRC thread and notice that, over the past nine months, you are practically the sole contributor.

You do extensive research. Your LONG postings are quite informative, in a general sense. However, as I read on, I got the feeling that if one has read one posting one has read them all. Problem: repetitiveness - extensive. Problem #2: it doesn't relate directly to HRC as an investment (although it points out problems in the hospital care industry).

Is there not an SI industry thread where these LENGTHY postings can more appropriately be deposited? After all, other hospital companies (e.g., HCA) and insurance companies are as much affected as HRC.

Thereafter, the posting here of a couple of summary paragraphs and a link would be adequate for those who want the read all the details.

Note that I don't quibble about the quality of your research. It's simply the redundancy of it overwhelms anything that might be posted here about HRC as a stock.



To: Tunica Albuginea who wrote (166)11/10/2001 6:48:40 PM
From: blankmind  Read Replies (1) | Respond to of 181
 
- earnings - trend looks good:
- '98: +.11
'99: - +.18
'00: .71
’01: -<.05>, .19, .20, .22 expected = +.56 - but the 1st qtr loss includes like $139 mill of one-time losses

- more importantly, in the 10/25/01 press release, they projected increased profits going forward of 15%: “is comfortable with fourth-quarter earnings per share of 22 cents and sustained earnings per share growth of 15 percent”